Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Match Group $700 million senior notes offering
The high-yield notes are due 2033
Eli Lilly $6.75 billion notes offering
The investment-grade offering consisted of seven tranches
Travel + Leisure $500 million senior secured notes offering
The high-yield notes are due 2033
NXP $1.5 billion senior notes offering
The investment-grade notes are due 2028, 2032 and 2035
PetSmart $2.7 billion notes offering
The high-yield notes are due 2032 and 2033
Centrus Energy $805 million convertible senior notes offering
The 0% convertible senior notes are due 2032
Circle $1.5 billion follow-on offering
We advised Circle on its first follow-on offering as a listed company on NYSE
Zoetis $1.85 billion senior notes offering
The investment-grade notes are due 2028 and 2035
Assurant $300 million senior notes offering
We advised Assurant on its investment-grade offering of senior notes
Qnity Electronics $1.75 billion notes offering
The debut high-yield notes are being offering in connection with the intended spinoff of Qnity